SaverOne Seeks Shareholder Approval for Reverse Split and Executive Equity Grants
SVRE sits 53% above its 52-week low of $2.02 on light trading volume (0.1× avg).
Summary
SaverOne's AGM proxy seeks approval for a reverse share split (1-for-5,000 to 1-for-15,000) and discloses RSU grants of ~3% of share capital each to the CEO and Chairman, plus 0.5% grants to three non-executive directors.
Key Events · Corporate Governance and Compliance · SVRE
-
Reverse Split Authorization Sought
Proposal 9 asks shareholders to approve a reverse share split at a ratio of 1-for-5,000 to 1-for-15,000, with the final ratio and effective date to be set by the Board. The ordinary share price on the TASE is currently 0.01 NIS, and the ADS ratio has been adjusted five times since October 2024 to 1 ADS per 43,200 Ordinary Shares.
-
CEO and Chairman Equity Grants
Proposals 6 and 7 disclose RSU grants of 3,252,484,800 Ordinary Shares (75,289 ADSs) each to CEO Ori Gilboa and Chairman Jacob Tenenbaum, representing approximately 3% of share capital on a fully diluted basis. Vesting is one-third immediately, one-third after 12 months, and one-third after 24 months, with full acceleration on change of control.
-
Non-Executive Director Grants
Proposal 8 grants each of Shlomo Shalev, Sharon Schreiber, and Yaron Be'eri 542,116,800 RSUs (12,549 ADSs), representing approximately 0.5% of share capital per director on a fully diluted basis.
-
Compensation Policy and Auditor Reappointment
The AGM also includes approval of an amended compensation policy, reappointment of Fahn Kanne & Co. Grant Thornton Israel as auditors, and re-election of Ori Gilboa and Shlomo Shalev to the Board.
Analysis · SVRE · Technology
SaverOne's 2026 AGM proxy includes a proposal to authorize a reverse share split at a ratio between 1-for-5,000 and 1-for-15,000, a move aimed at lifting the ordinary share price from its current 0.01 NIS level on the TASE. The proxy also details substantial equity grants to the CEO and Chairman—each receiving RSUs equal to about 3% of fully diluted share capital—plus smaller grants to three non-executive directors. With the company already under a going-concern warning and revenue down 63% in H1 2026, the reverse split is a critical step to maintain Nasdaq listing compliance and improve the ADS trading price, while the equity grants align management incentives with a potential turnaround.
At the time of this filing, SVRE was trading at $3.10 on NASDAQ in the Technology sector, with a market capitalization of approximately $336.2M. The 52-week trading range was $2.02 to $25.85. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.